Key result
Diagnostic and management strategies for fluoropyrimidine-induced chest pain are outlined to guide clinical care.
Key points are not available for this paper at this time.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The ATOMIC findings will likely lead to more patients receiving both ICI and FOLFOX concurrently and real-world experience will determine optimal management. Until evidence is available, clinicians must consider several potential causes in the workup of patients with symptoms.”
[Figure: see text]
No takes yet. Share an insight, caveat, or question.
Padegimas et al. (2020) studied this question. Diagnostic and management strategies for fluoropyrimidine-induced chest pain are outlined to guide clinical care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: